[6-(Methylcarbamoyl)pyridin-3-yl]boronic acid → HCID 76321980, compound
Reaction equation
[CH3:1][NH:2][C:3]([C:5]1[CH:10]=[CH:9][C:8](B(O)O)=[CH:7][N:6]=1)=[O:4].Cl[C:15]1[N:20]=[N:19][C:18]([N:21]2[CH2:26][CH2:25][CH:24]([N:27]3[C:35]4[C:30](=[CH:31][CH:32]=[C:33]([F:36])[CH:34]=4)[CH2:29][CH2:28]3)[CH2:23][CH2:22]2)=[CH:17][CH:16]=1>>[F:36][C:33]1[CH:34]=[C:35]2[C:30]([CH2:29][CH2:28][N:27]2[CH:24]2[CH2:25][CH2:26][N:21]([C:18]3[N:19]=[N:20][C:15]([C:8]4[CH:9]=[CH:10][C:5]([C:3]([NH:2][CH3:1])=[O:4])=[N:6][CH:7]=4)=[CH:16][CH:17]=3)[CH2:22][CH2:23]2)=[CH:31][CH:32]=1Participants
3
Procedure
The title compound was prepared following the procedure as described in Example 1, Method A, STEP 4, reacting 2-(N-methylaminocarbonyl)pyridine-5-boronic acid and 1-(1-(6-chloropyridazin-3-yl)piperidin-4-yl)-6-fluoroindoline.
Sources & evidence
- ORD record
- ord-c96977e1bb0d4c05a5b7d4cc56eb1ec3
- Source dataset
- uspto-grants-2015_08
- Patent number
- US09102669B2
Reaction notes
Loading…